OGN

Organon & Co.
Data: 2026-03-30
$5.7
Price
-2.40%
Change
$14.935
52W High
$5.69
52W Low

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Quick Stats
Mar 30, 2026

55.8

AI Score

HOLD

0.86

Volume Ratio

May 07, 2026

Next Earnings

10

+ve Days (30d)

20

-ve Days (30d)

OGN Stock Summary

Last updated Mar 30, 2026

OGN is currently trading at $5.7, positioned below its 200-day moving average of $8.53, suggesting bearish momentum. The stock has a 52-week range of $5.69 to $14.935.

Technical Analysis: The 50-day moving average stands at $7.44, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 23.985, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.269, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates OGN at 55.8/100 with a HOLD recommendation.

OGN (Organon & Co.) Indicators

Last updated Mar 30, 2026

Indicator Value
RSI(14) 23.985
CMF (20) -0.269
ROC (10) -9.858
ADX (14) 41.141
Indicator Value
MACD (12,26,9) -0.397
AROONOSC (14) -100.0
WILLAMS %R (14) -98.193
MFI (14) 32.925
OGN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

OGN Price vs Max Options Open Interest
OGN Max Change In Options Open Interest

OGN Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OGN Daily Out of Money Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OGN Daily In the Money Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

OGN Most Active Options by Volume(near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Organon & Co. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

OGN Moving Averages Analysis

OGN (Organon & Co.) Simple Moving Averages

Moving Averages are last updated Mar 30, 2026

Days MA
10 6.08
20 6.31
30 6.73
50 7.44
100 7.42
200 8.53

OGN Fundamental Analysis

P/E (Forward) 5.0302
P/E (Trailing) 8.4028
Market Cap ($) 1.6 billion
Earnings/Share ($) 0.72
Net Proft Margin (%) 0.0301
Dividend/Share ($) 0.34
EPS Estimate Current Year ($) 3.4671
EPS Estimate Next Year ($) 3.7268
WallStreet Target Price ($) 9
Most Recent Quarter